MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 188 filers reported holding MEDIVATION INC in Q2 2013. The put-call ratio across all filers is 0.41 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $115,227,000 | +93.5% | 1,910,901 | +47.5% | 0.06% | +93.8% |
| Q1 2016 | $59,550,000 | -32.4% | 1,295,121 | -29.0% | 0.03% | -22.0% |
| Q4 2015 | $88,146,000 | +8.3% | 1,823,453 | -4.8% | 0.04% | +17.1% |
| Q3 2015 | $81,383,000 | -5.2% | 1,914,879 | +154.6% | 0.04% | -5.4% |
| Q2 2015 | $85,881,000 | +0.1% | 752,015 | +13.2% | 0.04% | -7.5% |
| Q1 2015 | $85,770,000 | +23.4% | 664,523 | -4.8% | 0.04% | +42.9% |
| Q4 2014 | $69,525,000 | -14.7% | 697,978 | -15.3% | 0.03% | -9.7% |
| Q3 2014 | $81,505,000 | +23.9% | 824,366 | -3.4% | 0.03% | +6.9% |
| Q2 2014 | $65,763,000 | -23.7% | 853,164 | -36.3% | 0.03% | -27.5% |
| Q1 2014 | $86,202,000 | -17.8% | 1,339,156 | -18.5% | 0.04% | -16.7% |
| Q4 2013 | $104,852,000 | -9.6% | 1,642,952 | -15.1% | 0.05% | -21.3% |
| Q3 2013 | $116,045,000 | +192.8% | 1,936,014 | +140.3% | 0.06% | +177.3% |
| Q2 2013 | $39,632,000 | – | 805,536 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |